ProFunds Fund Family Report
|
Performance
06-30-17
Total ReturnCategory
Average
| Total Return | 38.17 | 19.69 | 4.53 | 8.95 | 13.74 |
| Category Average | 3.08 | -0.34 | 0.18 | 1.68 | 0.60 |
| Assets for Each Yr* | 2.76 | 2.95 | 2.34 | 2.47 | 2.37 |
*billions
Trailing Returns %
06-30-17
| YTD | 3 Year | 5 Year | |||
|---|---|---|---|---|---|
| Fund Family | 13.74 | 12.92 | 17.74 | ||
Key Stats
06-30-17
| Total Assets* | Min. Investment | Load (% of Assets) | No Load (% of Assets) |
|---|---|---|---|
| $2,370 mil | $15,000 | 5.12 | 94.88 |
| Asset Class | Score | % of Assets | Expense Ratio % | Expense Rating |
| Domestic Stock | 2.8 | 10.33 | 2.23 | Very High |
| International Stock | 2.0 | 0.38 | 2.28 | Very High |
| Municipal Bond | -- | -- | -- | -- |
| Taxable Bond | 2.6 | 1.44 | 2.14 | Very High |
*Doesn't include money market assets.
Top 20 US Holdings | Get Price Quotes
07-25-17
| Sector | YTD Return % | % Net Assets | ||
|---|---|---|---|---|
| Amgen Inc* | Healthcare | 25.29 | 1.69 | |
| Apple Inc* | Technology | 32.91 | 1.62 | |
| Intel Corp* | Technology | -2.94 | 1.40 | |
| Celgene Corp* | Healthcare | 17.87 | 1.36 | |
| AbbVie Inc* | Healthcare | 18.88 | 1.33 | |
| Gilead Sciences Inc* | Healthcare | 4.43 | 1.26 | |
| Amazon.com Inc* | Consumer Cyclical | 38.67 | 1.16 | |
| Microsoft Corp* | Technology | 20.65 | 1.13 | |
| Facebook Inc A* | Technology | 43.66 | 0.97 | |
| Biogen Inc* | Healthcare | 5.94 | 0.83 | |
| Alphabet Inc C* | Technology | 23.18 | 0.77 | |
| Alphabet Inc A* | Technology | 22.28 | 0.72 | |
| Qualcomm Inc* | Technology | -16.61 | 0.65 | |
| Texas Instruments Inc* | Technology | 12.91 | 0.65 | |
| NVIDIA Corp* | Technology | 55.17 | 0.50 | |
| Regeneron Pharmaceuticals Inc* | Healthcare | 39.87 | 0.43 | |
| Comcast Corp Class A* | Communication Services | 16.05 | 0.42 | |
| Vertex Pharmaceuticals Inc* | Healthcare | 119.86 | 0.41 | |
| Alexion Pharmaceuticals Inc* | Healthcare | 5.72 | 0.40 | |
| Illumina Inc* | Healthcare | 35.78 | 0.38 | |
Best 5-Year Relative Performance | More
07-25-17
| Fund Name | 5-Yr Rank | Analyst Report | ||
|---|---|---|---|---|
| ProFunds UltraShort Latin Am | 5 | -- | ||
| ProFunds NASDAQ-100 Inv | 10 | -- | ||
| ProFunds Bear Inv | 18 | -- | ||
| Access Flex High Yield Inv | 28 | -- | ||
| ProFunds Short Small Cap Inv | 37 | -- | ||
Worst 5-Year Relative Performance | More
07-25-17
| Fund Name | 5-Yr Rank | Analyst Report | ||
|---|---|---|---|---|
| ProFunds UltraShort Japan In | 98 | -- | ||
| ProFunds Falling US Dollar I | 97 | -- | ||
| ProFunds UltraShort NASDAQ-1 | 92 | -- | ||
| ProFunds Europe 30 Inv | 89 | -- | ||
| ProFunds UltraShort China In | 87 | -- | ||
Lowest Expenses | More
07-25-17
| Fund Name | Expense Ratio | Analyst Report | ||
|---|---|---|---|---|
| ProFunds US Government Plus | 1.27 | -- | ||
| ProFunds UltraBull Inv | 1.46 | -- | ||
| ProFunds Biotechnology Ultra | 1.47 | -- | ||
| ProFunds UltraNASDAQ-100 Inv | 1.47 | -- | ||
| ProFunds Rising Rates Opp In | 1.48 | -- | ||
Highest Expenses | More
07-25-17
| Fund Name | Expense Ratio | Analyst Report | ||
|---|---|---|---|---|
| ProFunds Short Precious Meta | 1.86 | -- | ||
| ProFunds UltraChina Inv | 1.85 | -- | ||
| ProFunds Small Cap Value Inv | 1.81 | -- | ||
| ProFunds Ultra International | 1.81 | -- | ||
| ProFunds Short Oil & Gas Inv | 1.80 | -- | ||
Longest Manager Tenure | More
07-25-17
| Fund Name | Manager Name | Avg Manager Tenure | ||
|---|---|---|---|---|
| Access Flex High Yie | Jeffrey Ploshnick | 6.80 | ||
| Access Flex Bear Hig | Jeffrey Ploshnick | 6.60 | ||
| ProFunds Europe 30 I | Alexander V. Ilyasov | 4.30 | ||
| ProFunds Falling US | Jeffrey Ploshnick | 4.30 | ||
| ProFunds Rising Rate | Michelle Liu | 4.30 | ||
Shortest Manager Tenure | More
07-25-17
| Fund Name | Manager Name | Avg Manager Tenure | ||
|---|---|---|---|---|
| ProFunds Banks Ultra | Michael Neches | 2.30 | ||
| ProFunds Basic Mater | Michael Neches | 2.30 | ||
| ProFunds Biotechnolo | Michael Neches | 2.30 | ||
| ProFunds Consumer Go | Michael Neches | 2.30 | ||
| ProFunds Consumer Se | Michael Neches | 2.30 | ||